The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of afatinib in recurrent and/or metastatic esophageal squamous cell carcinoma (R/M ESCC) (KCSG HN14-18).
 
Min Hee Hong
No Relationships to Disclose
 
Yun-Gyoo Lee
No Relationships to Disclose
 
Hyo Song Kim
No Relationships to Disclose
 
Keon Uk Park
No Relationships to Disclose
 
Hoon-Gu Kim
No Relationships to Disclose
 
Yoon Ho Ko
No Relationships to Disclose
 
Ik-Joo Chung
No Relationships to Disclose
 
Young Joo Min
No Relationships to Disclose
 
Min Kyoung Kim
No Relationships to Disclose
 
HyeRyun Kim
Consulting or Advisory Role - Novartis
 
Byoung Chul Cho
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
Research Funding - GlaxoSmithKline; Merck